Standard BioTools (LAB) News Today → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free LAB Stock Alerts $2.48 +0.08 (+3.33%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading Up 8.5%Standard BioTools (NASDAQ:LAB) Stock Price Up 8.5%May 8, 2024 | investorplace.comLAB Stock Earnings: Standard BioTools Reported Results for Q1 2024May 8, 2024 | globenewswire.comStandard BioTools Reports First Quarter 2024 Financial ResultsMay 1, 2024 | marketbeat.comStandard BioTools (LAB) Set to Announce Quarterly Earnings on WednesdayStandard BioTools (NASDAQ:LAB) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=497828)April 27, 2024 | investing.comStandard BioTools to cut costs with restructuring planApril 26, 2024 | finanznachrichten.deStandard BioTools Inc.: Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthApril 25, 2024 | globenewswire.comStandard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthApril 17, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Sees Large Volume IncreaseStandard BioTools (NASDAQ:LAB) Sees Unusually-High Trading VolumeApril 16, 2024 | msn.comTD Cowen Initiates Coverage of Standard BioTools (LAB) with Buy RecommendationApril 16, 2024 | finance.yahoo.comStandard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?April 16, 2024 | marketbeat.comTD Cowen Initiates Coverage on Standard BioTools (NASDAQ:LAB)TD Cowen began coverage on Standard BioTools in a report on Tuesday. They set a "buy" rating and a $3.50 price objective on the stock.April 15, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Sees Significant Increase in Short InterestStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 10,230,000 shares, an increase of 10.5% from the March 15th total of 9,260,000 shares. Approximately 2.7% of the shares of the company are short sold. Based on an average daily volume of 2,170,000 shares, the days-to-cover ratio is currently 4.7 days.April 8, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading 5.8% Higher Standard BioTools (NASDAQ:LAB) Trading Up 5.8%April 8, 2024 | globenewswire.comStandard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingApril 5, 2024 | investing.comStandard BioTools secures deal with Bristol Myers SquibbApril 4, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Standard BioTools (LAB)April 4, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Up to $2.66Standard BioTools (NASDAQ:LAB) Shares Gap Up to $2.66April 4, 2024 | marketbeat.comJefferies Financial Group Initiates Coverage on Standard BioTools (NASDAQ:LAB)Jefferies Financial Group started coverage on shares of Standard BioTools in a research report on Thursday. They set a "buy" rating and a $3.25 price objective for the company.April 3, 2024 | globenewswire.comStandard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchApril 2, 2024 | finance.yahoo.comIs Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)?March 29, 2024 | msn.comNikon, Lunaphore team up for spatial biology servicesMarch 21, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading 6.9% Higher Standard BioTools (NASDAQ:LAB) Shares Up 6.9%March 20, 2024 | investing.comStandard BioTools swaps preferred for common stockMarch 19, 2024 | finance.yahoo.comEstimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)March 18, 2024 | msn.comStandard Biotools exchanges all outstanding Series B convertible preferred stock for common stockMarch 18, 2024 | globenewswire.comStandard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockMarch 16, 2024 | insidertrades.comStandard BioTools Inc. (NASDAQ:LAB) Director Acquires $642,500.00 in StockMarch 5, 2024 | finance.yahoo.comStandard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | seekingalpha.comStandard BioTools Inc. (LAB) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comStandard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineMarch 1, 2024 | marketbeat.comHighTower Advisors LLC Sells 593,616 Shares of Standard BioTools Inc. (NASDAQ:LAB)HighTower Advisors LLC lessened its holdings in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 75.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,670 shares of the company's stock after selling 593,616February 29, 2024 | finance.yahoo.comQ4 2023 Standard BioTools Inc Earnings CallFebruary 28, 2024 | finance.yahoo.comStandard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ...February 28, 2024 | globenewswire.comStandard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 26, 2024 | finance.yahoo.comStandard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingFebruary 23, 2024 | marketbeat.comEAM Investors LLC Makes New $1.38 Million Investment in Standard BioTools Inc. (NASDAQ:LAB)EAM Investors LLC bought a new position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 473,982 shares of the company's stock, valued at aFebruary 22, 2024 | globenewswire.comStandard BioTools to Participate in Upcoming Investor ConferencesFebruary 22, 2024 | benzinga.comStandard BioTools Stock (NASDAQ:LAB), Short Interest ReportFebruary 18, 2024 | msn.comMedical lab technologist faces 25 urine-tampering chargesFebruary 16, 2024 | finance.yahoo.comLAB Feb 2024 0.500 putFebruary 15, 2024 | washingtonpost.comCLIMATE LABFebruary 14, 2024 | finance.yahoo.comStandard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024February 14, 2024 | globenewswire.comStandard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024February 7, 2024 | markets.businessinsider.comStandard BioTools To Collaborate With NavignosticsFebruary 7, 2024 | finance.yahoo.comStandard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineFebruary 5, 2024 | msn.comRequirements to operate a private clinical laboratoryFebruary 3, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Stock Price Up 6.1%Standard BioTools (NASDAQ:LAB) Trading 6.1% HigherJanuary 19, 2024 | ca.finance.yahoo.comStandard BioTools Inc. (LAB)January 8, 2024 | finanznachrichten.deStandard BioTools Inc.: Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 RevenueJanuary 8, 2024 | finance.yahoo.comInsider Buyers Lose US$33k As Standard BioTools Sheds US$27m Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide LAB Media Mentions By Week LAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAB News Sentiment▼-0.190.57▲Average Medical News Sentiment LAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAB Articles This Week▼62▲LAB Articles Average Week Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Quanterix News EyePoint Pharmaceuticals News Cytek Biosciences News Pacific Biosciences of California News Adaptive Biotechnologies News Nautilus Biotechnology News Akoya Biosciences News Treace Medical Concepts News HilleVax News Bicycle Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
